Soft tissue malignancies in childhood and adolescence. Pathology and clinical relevance based on data from the Kiel Pediatric Tumor Registry;Weichteilmalignome bei kindern und jugendlichen - Pathologische anatomie und ihre klinische relevanz: Mit daten aus dem Kieler Kindertumorregister

Handchirurgie Mikrochirurgie Plastische Chirurgie

Volumn 36, Issue 5, 2004, Pages 268-274

  Harms, Dieter ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Kiel Pediatric Tumor Registry; Peripheral primitive neuroectodermal tumors; Rhabdomyosarcomas; Soft tissue sarcomas; Tumor statistic

Indexed keywords

ADOLESCENT; ALVEOLAR SOFT PART SARCOMA; CANCER INCIDENCE; CANCER REGISTRY; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; COMPARATIVE STUDY; EWING SARCOMA; FIBROHISTIOCYTOMA; FIBROSARCOMA; GENETIC ANALYSIS; GERMANY; HISTOPATHOLOGY; HUMAN; INFORMATION PROCESSING; MEDICAL LITERATURE; MOLECULAR BIOLOGY; NERVE CELL DIFFERENTIATION; NERVE SHEATH TUMOR; NEUROECTODERM TUMOR; PROGNOSIS; REVIEW; RHABDOID TUMOR; RHABDOMYOSARCOMA; SOFT TISSUE CANCER; STATISTICAL ANALYSIS; SYNOVIAL SARCOMA; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

ADOLESCENT; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; CONNECTIVE TISSUE; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; INFANT; LYMPH NODES; MUSCLE, SKELETAL; PROGNOSIS; REGISTRIES; RHABDOMYOSARCOMA, ALVEOLAR; RHABDOMYOSARCOMA, EMBRYONAL; SOFT TISSUE NEOPLASMS;

EID: 7544227452     PISSN: 07221819     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-817954     Document Type: Review

References (17)

1. Bourgeois JM, Knezevich SR, Mathers JA, Sorensen PHB: Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors. Am J Surg Pathol 2000; 24: 937-946
2. Cessna MH, Zhou H, Perkins SL, Tripp SR, Layfield L, Daines C, Coffin CM: Are myogenin and MyoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 2001; 25: 1150-1157
3. Coffin CM, Rulon J, Smith L, Bruggers C, White FV: Pathologic features of rhabdomyosarcoma before and after treatment: A clinicopathologic and immunohistochemical analysis. Mod Pathol 1997; 10: 1175-1187
4. Harms D: Alveolar rhabdomyosarcoma: A prognostically unfavorable rhabdomyosarcoma type and its necessary distinction from embryonal rhabdomyosarcoma. In: Harms D, Schmidt D (Eds): Soft Tissue Tumors. Berlin, Heidelberg: Springer 1995: 273-296
5. Harms D, Krams M, Leuschner I: Weichgewebstumoren des Kindesund Adoleszentenalters. Bedeutung für die Klinik. Onkologe 2002; 8: 320-333
6. Harms D, Leuschner I, Krams M, Pilgrim TB, Treuner J: Rhabdomyosarkome und extraossäre Ewing-Sarkome. Verh Dtsch Ges Path 1998; 82: 83-98
7. Kelly KM, Womer RB, Sorensen PHB, Xiong QB, Barr FG: Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 1997; 15: 1831-1836
8. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH: A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 1998; 18: 184-187
9. Koscielniak E, Harms D, Henze G, Jürgens H, Gadner H, Herbst M, Klingebiel T, Schmidt BF, Morgan M, Knietig R, Treuner J: Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 1999; 17: 3706-3719
10. Leuschner I, Heuer T, Harms D: Induction of drug resistance in human rhabdomyosarcoma cell lines is associated with increased maturation: possible explanation for differentiation in recurrences? Pediatr Dev Pathol 2002; 5: 276-282
11. Loh ML, Ahn P, Perez-Atayde AR, Gebhardt MC, Schamberger RC, Grier HE: Treatment of infantile fibrosarcoma with chemotherapy and surgery: Results from the Dana-Farber Cancer Institute and Children's Hospital, Boston. J Pediatr Hematol Oncol 2002; 24: 722-726
12. Neville HL, Andrassy RJ, Lobe TE, Bagwell CE, Anderson JR, Womer RB, Crist WM, Wiener ES: Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). J Pediatr Surg 2000; 35: 317-321
13. Schmidt D, Herrmann C, Jürgens H, Harms D: Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma. A report from the Kiel Pediatric Tumor Registry. Cancer 1991; 68: 2251-2259
14. Sorensen PHB, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ, Barr FG for the Soft Tissue Sarcoma Committee, representing the Children's Oncology Group. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: A report from the Children's Oncology Group. J Clin Oncol 2002; 20: 2672-2679
15. th ed. Philadelphia: Lippincott Williams & Wilkins, 2002: 164-204
16. Tsokos M, Webber BL, Parham DM, Wesley RA, Miser A, Miser JS, Etcubanas E, Kinsella T, Grayson J, Glatstein E, Pizzo PA, Triche TJ: Rhabdo-myosarcoma. A new classification scheme related to prognosis. Arch Pathol Lab Med 1992; 116: 847-855
17. Weiss SW, Goldblum JR: Enzinger and Weiss's Soft Tissue Tumors. St. Louis: Mosby, 2001